Danaher Corp. (DHR)

102.30
0.89 0.88
NYSE : Health Technology
Prev Close 101.41
Open 101.16
Day Low/High 101.12 / 102.35
52 Wk Low/High 78.97 / 104.82
Volume 2.05M
Avg Volume 2.17M
Exchange NYSE
Shares Outstanding 698.57M
Market Cap 71.42B
EPS 3.60
P/E Ratio 28.32
Div & Yield 0.64 (0.57%)

Latest News

Weekly Roundup

The markets strongly rebounded this week as a few of the major averages pushed into positive year-to-date territory.

Emotions Are Running This Market: Cramer's 'Mad Money' Recap (Tuesday 5/8/18)

Emotions Are Running This Market: Cramer's 'Mad Money' Recap (Tuesday 5/8/18)

Jim Cramer says the reason this market is so hard to deal with is that it doesn't know how to calculate an event -- even when everyone saw it coming.

Danaher Announces Quarterly Dividend

Weekly Roundup

A strong Friday failed to keep markets in positive territory.

Charts Say Danaher Could Rally Some 50% From Here

Charts Say Danaher Could Rally Some 50% From Here

Charts say the $99 stock could rise as high as $150 or so.

Snap, Costco, Seagate Technology: 'Mad Money' Lightning Round

Snap, Costco, Seagate Technology: 'Mad Money' Lightning Round

Jim Cramer shines a spotlight on Snap, Costco, Seagate Technology, GW Pharmaceuticals, Danaher, General Mills and more.

Haters Gonna Hate: Cramer's 'Mad Money' Recap (Wednesday 5/2/18)

Haters Gonna Hate: Cramer's 'Mad Money' Recap (Wednesday 5/2/18)

We have a wall of worry to overcome, but it's important to hear the other side of the trade, says Jim Cramer. Take Apple and Facebook, for example.

Beckman Coulter Launches The DxH 900 Hematology Analyzer

System helps laboratories deliver fast, accurate results through near native-state cellular characterization, precise flagging and a 93% first-pass throughput[1]

Weekly Roundup

Markets end flat for week as strong earnings fail to excite investors.

A Closer Look at MMM, ITW

These are broken stocks right now, not broken companies.

Last Week's Portfolio Changes

We raised one price target and downgraded three names last week.

Weekly Roundup

Markets give up some gains Thursday and Friday, ahead of heavy earnings next week.

Market Weakness Shows Need For Discipline

Sales into strength leave us with money to put to work during earnings season.

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump

Stocks on Wall Street declined Thursday amid a host of earnings reports.

Adding to Nordstrom

Today's weakness is the opportunity we have been patiently waiting for.

Jim's Daily Rundown

Jim discusses earnings from Nucor and Danaher, recent headlines about Apple, Amazon, Allergan, and more!

Danaher Reports 1Q Result

Overall, it was another great quarter for Danaher.

Starbucks Leaves a Bitter Taste and Doesn't Suit My Investment Palate Either

Starbucks Leaves a Bitter Taste and Doesn't Suit My Investment Palate Either

For my portfolio, you can't beat this SBUX competitor -- and for a cup of coffee.

Amazon, Procter & Gamble, Southwest and Netflix - 5 Things You Must Know

Amazon, Procter & Gamble, Southwest and Netflix - 5 Things You Must Know

U.S. stock futures point lower; surging oil prices boost equities in Europe and Asia; Amazon says its Prime subscription program has more than 100 million members; P&G to buy German Merck's consumer healthcare unit for $4.2 billion.

Dropbox, Qualcomm, Skechers: 'Mad Money' Lightning Round

Dropbox, Qualcomm, Skechers: 'Mad Money' Lightning Round

Jim Cramer focuses on Dropbox, Qualcomm, Skechers USA, Spotify, Nucor, Kratos Defense & Security, American Water Works.

Technology Is Fueling Gains: Cramer's 'Mad Money' Recap (Wednesday 4/18/18)

Technology Is Fueling Gains: Cramer's 'Mad Money' Recap (Wednesday 4/18/18)

How do you get a stock moving? Jim Cramer says the answer is to invest in technology.

Revance Therapeutics: Cramer's Top Takeaways

Revance Therapeutics: Cramer's Top Takeaways

Dan Browne, co-founder, president and CEO of Revance Therapeutics, tells Jim Cramer his company is developing an alternative to Botox.

CyrusOne: Cramer's Top Takeaways

CyrusOne: Cramer's Top Takeaways

Gary Wojtaszek, president and CEO of CyrusOne, tells Jim Cramer about the $442 million acquisition of Zenium.

Trimming Illinois Tool Works and Danaher

We continue to look for opportunities to lock in strong profits and build up our cash position

Seven Portfolio Companies Report This Week

Latest results due from UnitedHealth, Goldman Sachs, Abbott and more.

Weekly Roundup

The markets bounced back on easing trade tensions and the banks kicked off first-quarter earnings season.

Keeping Cash Ready For the Right Moment

Increased volatility makes it more important than ever to maintain discipline and keep cash ready.

TheStreet Quant Rating: A- (Buy)